Author: iData Research
DePuy Synthes Launches The First 3D Simulation Assisted Orthopaedic External Circular Fixation Device For Patients With Limb Deformity
MAXFRAME™ Multi-Axial Correction System helps improve accuracy of the deformity correction plan, which may reduce overall treatment time while potentially improving procedural efficiency and reducin... Read More
Sutureless Tissue Heart Valves, Reinvigorating the Market
Heart valve replacement procedures are a type of cardiac surgery. Generally, heart valve replacement is an open operation. However, recent advancements in technology has allowed for minimally invasive... Read More
ResMed Wins German Patent Infringement Case Brought by Fisher & Paykel
ResMed's AirSense 10, AirCurve 10 and Lumis products do not infringe German utility model patent... Read More
Cogentix Medical Makes $2 Million Investment in Israeli Company Developing Innovative and Novel Device for Delivery of Drugs to the Bladder
The ability to offer another minimally invasive treatment option and significantly increase the number of patients who receive a 3rd line therapy for OAB is truly an exciting opportunity to leverage V... Read More
DentalEZ Announces Partnership with PSA and Welcomes DHD as Master Distributor in UK
DentalEZ is partnering with PSA, Professional Sales Associates, Inc., on sales of its StarDental®, RAMVAC® and DentalEZ Equipment brands to dental distributors in the US, Puerto Rico and Canada and ... Read More
Phoenix Children’s Hospital is the First in Arizona to Offer New FDA Approved Epilepsy Treatment by LivaNova
The latest Vagus Nerve Stimulation Therapy® ("VNS Therapy") System through LivaNova PLC features the recently FDA-approved SenTiva™ implantable generator, the smallest and lightest responsive thera... Read More
Biosimilars – A Game Changer in the Immunology Rheumatoid Arthritis Market
Biosimilars are, as the name would suggest, highly similar and are a more affordable alternative to biologics that is poised to influence the current dynamics of the immunology market. ... Read More
AbbVie, Johnson & Johnson Lead US Immunology Drug Market Due to High Cost of Biologic Treatments
The U.S. immunology drug market is expected to grow to $68 billion by 2023 due to the entry of new biosimilars and JAK inhibitors.... Read More
